“骗保”案的道德困境治疗癌症的代价与医保的规范最近闹得沸沸扬扬的“骗保”案，最终很多涉案人员都被判处不同程度的刑罚。然而，很多人在谴责医保局和医保政策，今天从个人角度简单说说这件事的想法。涉案的药物叫做Osimertinib ...

Get detailed information on Garenoxacin Mesylate, including pronunciation, uses, dosage guidelines, indications, and instructions on how and when to take it and when to avoid it. The updated ...

There are also oral medications in phase III based on a possible action against tau, such as simufilam and ...

Eribulin exerts its pharmacologic effects by binding to the plus ends of microtubules and suppressing microtubule growth, without affecting microtubule shortening, and by inducing the formation of ...

回顾2024ASCO大会HER2阳性晚期乳腺癌治疗领域最新研究进展。 2024年美国临床肿瘤学会（ASCO）年会于5月31日-6月4日在芝加哥盛大召开，作为全球最有 ...

The FDA approved zolbetuximab (Vyloy) on October 18, 2024, as a first-line treatment for locally advanced unresectable or ...

For chronic myeloid leukemia (CML) patients, there is a promising new first-line drug approval with asciminib (brand name ...

Boyle's research team also found that the 2GF-mediated increase in proinflammatory cytokine levels in fibroblast-like synoviocytes could be inhibited by treatment with imatinib mesylate—a ...

Purpose: The pharmacology, pharmacokinetics, clinical efficacy, and safety of rasagiline are reviewed. Summary: Rasagiline is a novel, investigational propargylamine that irreversibly and ...

NICE has said it expects to evaluate dozens of potential treatments for Alzheimer’s disease over the next few years. Elisabeth Mahase examines what we know about these drugs This year the National ...

Thus far, CETF has raised funding for clinical trials for drug candidates including Peginterferon lambda, a hepatitis D treatment, and Camostat mesylate, a protease inhibitor used to treat reflux ...